{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T08:15:04Z","timestamp":1777277704937,"version":"3.51.4"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T00:00:00Z","timestamp":1694476800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82002648"],"award-info":[{"award-number":["82002648"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82102898"],"award-info":[{"award-number":["82102898"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82173175"],"award-info":[{"award-number":["82173175"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003345","name":"Chinese Academy of Meteorological Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003345","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004829","name":"Science and Technology Department of Sichuan Province","doi-asserted-by":"publisher","award":["2022YFS0321"],"award-info":[{"award-number":["2022YFS0321"]}],"id":[{"id":"10.13039\/501100004829","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["World Neurosurgery"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.wneu.2023.08.137","type":"journal-article","created":{"date-parts":[[2023,9,6]],"date-time":"2023-09-06T10:24:36Z","timestamp":1693995876000},"page":"e117-e126","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Case Report: Successful Use of BRAF\/MEK Inhibitors in Aggressive BRAF-mutant Craniopharyngioma"],"prefix":"10.1016","volume":"180","author":[{"given":"Ze-Pei","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6457-0481","authenticated-orcid":false,"given":"Yue-Long","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-Chong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi-Yong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rang-Rang","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Zan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui-Chao","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin-Long","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liang-Xue","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian-Guo","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.wneu.2023.08.137_bib1","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1586\/14737175.2014.875470","article-title":"Childhood craniopharyngioma: treatment strategies and outcomes","volume":"14","author":"M\u00fcller","year":"2014","journal-title":"Expert Rev Neurother"},{"key":"10.1016\/j.wneu.2023.08.137_bib2","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.ccr.2014.07.007","article-title":"Structure of the BRAF-MEK complex reveals a kinase activity independent role for BRAF in MAPK signaling","volume":"26","author":"Haling","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.wneu.2023.08.137_bib3","doi-asserted-by":"crossref","first-page":"3446","DOI":"10.1002\/cncr.28864","article-title":"The MAPK pathway across different malignancies: a new perspective","volume":"120","author":"Burotto","year":"2014","journal-title":"Cancer"},{"key":"10.1016\/j.wneu.2023.08.137_bib4","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/S0092-8674(04)00215-6","article-title":"Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF","volume":"116","author":"Wan","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.wneu.2023.08.137_bib5","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1038\/sj.bjc.6605714","article-title":"Recovery of phospho-ERK activity allows melanoma cells to escape from BRAF inhibitor therapy","volume":"102","author":"Paraiso","year":"2010","journal-title":"Br J Cancer"},{"key":"10.1016\/j.wneu.2023.08.137_bib6","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/ng.2868","article-title":"Exome sequencing identifies BRAF mutations in papillary craniopharyngiomas","volume":"46","author":"Brastianos","year":"2014","journal-title":"Nat Genet"},{"key":"10.1016\/j.wneu.2023.08.137_bib7","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/j.1365-2265.2005.02231.x","article-title":"Craniopharyngiomas in children and adults: systematic analysis of 121 cases with long-term follow-up","volume":"62","author":"Karavitaki","year":"2005","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.wneu.2023.08.137_bib8","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.ijrobp.2014.01.019","article-title":"Long-term outcomes and complications in patients with craniopharyngioma: the British Columbia Cancer Agency experience","volume":"88","author":"Lo","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.wneu.2023.08.137_bib9","article-title":"Dramatic therapeutic response to dabrafenib plus trametinib in BRAF V600E mutated papillary craniopharyngiomas: a case report and literature review","volume":"8","author":"Fasano","year":"2021","journal-title":"Front Med"},{"key":"10.1016\/j.wneu.2023.08.137_bib10","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1093\/neuonc\/nox056","article-title":"Intracystic interferon-alpha in pediatric craniopharyngioma patients: an international multicenter assessment on behalf of SIOPE and ISPN","volume":"19","author":"Kilday","year":"2017","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.wneu.2023.08.137_bib11","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgaa089","article-title":"Growth hormone therapy does not increase the risk of craniopharyngioma and nonfunctioning pituitary adenoma recurrence","volume":"105","author":"Losa","year":"2020","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.wneu.2023.08.137_bib12","doi-asserted-by":"crossref","first-page":"791","DOI":"10.3389\/fonc.2019.00791","article-title":"Targeting IL-6 is a potential treatment for primary cystic craniopharyngioma","volume":"9","author":"Grob","year":"2019","journal-title":"Front Oncol"},{"key":"10.1016\/j.wneu.2023.08.137_bib13","doi-asserted-by":"crossref","first-page":"E7","DOI":"10.3171\/2019.10.FOCUS19705","article-title":"Adamantinomatous craniopharyngioma: moving toward targeted therapies","volume":"48","author":"Hengartner","year":"2020","journal-title":"Neurosurg Focus"},{"key":"10.1016\/j.wneu.2023.08.137_bib14","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1200\/JCO.2021.39.15_suppl.2000","article-title":"Alliance A071601: phase II trial of BRAF\/MEK inhibition in newly diagnosed papillary craniopharyngiomas","volume":"39","author":"Brastianos","year":"2021","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.wneu.2023.08.137_bib15","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djv310","article-title":"Dramatic response of BRAF V600E mutant papillary craniopharyngioma to targeted therapy","volume":"108","author":"Brastianos","year":"2016","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.wneu.2023.08.137_bib16","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1007\/s11102-015-0663-4","article-title":"Pronounced response of papillary craniopharyngioma to treatment with vemurafenib, a BRAF inhibitor","volume":"19","author":"Aylwin","year":"2016","journal-title":"Pituitary"},{"key":"10.1016\/j.wneu.2023.08.137_bib17","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2217\/cns-2016-0034","article-title":"BRAF-V600E mutant papillary craniopharyngioma dramatically responds to combination BRAF and MEK inhibitors","volume":"6","author":"Roque","year":"2017","journal-title":"CNS Oncol"},{"key":"10.1016\/j.wneu.2023.08.137_bib18","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1007\/s00701-017-3311-0","article-title":"Recurrent papillary craniopharyngioma with BRAFV600E mutation treated with neoadjuvant-targeted therapy","volume":"159","author":"Rostami","year":"2017","journal-title":"Acta Neurochir"},{"key":"10.1016\/j.wneu.2023.08.137_bib19","first-page":"1299","article-title":"Recurrent papillary craniopharyngioma with BRAF V600E mutation treated with dabrafenib: case report","volume":"130","author":"Himes","year":"2018","journal-title":"J\u00a0Neurosurg"},{"key":"10.1016\/j.wneu.2023.08.137_bib20","doi-asserted-by":"crossref","first-page":"2910","DOI":"10.1002\/cncr.32197","article-title":"Targeted treatment of papillary craniopharyngiomas harboring BRAF V600E mutations","volume":"125","author":"Juratli","year":"2019","journal-title":"Cancer"},{"key":"10.1016\/j.wneu.2023.08.137_bib21","doi-asserted-by":"crossref","first-page":"6038","DOI":"10.18632\/oncotarget.27203","article-title":"Newly diagnosed papillary craniopharyngioma with BRAF V600E mutation treated with single-agent selective BRAF inhibitor dabrafenib: a case report","volume":"10","author":"Rao","year":"2019","journal-title":"Oncotarget"},{"key":"10.1016\/j.wneu.2023.08.137_bib22","first-page":"1704","article-title":"Dual BRAF\/MEK therapy in BRAF V600E-mutated primary brain tumors: a case series showing dramatic clinical and radiographic responses and a reduction in cutaneous toxicity","volume":"133","author":"Bernstein","year":"2019","journal-title":"J\u00a0Neurosurg"},{"key":"10.1016\/j.wneu.2023.08.137_bib23","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.6004\/jnccn.2020.7624","article-title":"Successful use of BRAF\/MEK inhibitors as a neoadjuvant approach in the definitive treatment of papillary craniopharyngioma","volume":"18","author":"Khaddour","year":"2020","journal-title":"J\u00a0Natl Compr Canc Netw"},{"key":"10.1016\/j.wneu.2023.08.137_bib24","article-title":"Medical debulking with BRAF\/MEK inhibitors in aggressive BRAF-mutant craniopharyngioma","volume":"2","author":"Di Stefano","year":"2020","journal-title":"Neurooncol Adv"},{"key":"10.1016\/j.wneu.2023.08.137_bib25","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1212\/WNL.94.15_supplement.867","article-title":"Initial presentation of papillary craniopharyngioma with BRAF mutation treated with adjuvant chemotherapy (867)","volume":"94","author":"Gopal","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.wneu.2023.08.137_bib26","article-title":"Aggressive childhood-onset papillary craniopharyngioma managed with vemurafenib, a BRAF inhibitor","volume":"5","author":"Chik","year":"2021","journal-title":"J\u00a0Endocr Soc"},{"key":"10.1016\/j.wneu.2023.08.137_bib27","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1111\/jcpt.13600","article-title":"Case report and literature review of BRAF-V600 inhibitors for treatment of papillary craniopharyngiomas: a potential treatment paradigm shift","volume":"47","author":"Nussbaum","year":"2022","journal-title":"J\u00a0Clin Pharm Ther"},{"key":"10.1016\/j.wneu.2023.08.137_bib28","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.882381","article-title":"Neoadjuvant B-RAF and MEK inhibitor targeted therapy for adult papillary craniopharyngiomas: a new treatment paradigm","volume":"13","author":"Calvanese","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.wneu.2023.08.137_bib29","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s00381-018-3925-4","article-title":"Papillary craniopharyngioma in a 4-year-old girl with BRAF V600E mutation: a case report and review of the literature","volume":"35","author":"Borrill","year":"2019","journal-title":"Childs Nerv Syst"},{"key":"10.1016\/j.wneu.2023.08.137_bib30","doi-asserted-by":"crossref","first-page":"5751","DOI":"10.1210\/jc.2019-01299","article-title":"The medical therapy of craniopharyngiomas: the way ahead","volume":"104","author":"Alexandraki","year":"2019","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.wneu.2023.08.137_bib31","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1186\/s12883-021-02368-5","article-title":"Primary ectopic parasellar craniopharyngioma: a case report","volume":"21","author":"Cai","year":"2021","journal-title":"BMC Neurol"},{"key":"10.1016\/j.wneu.2023.08.137_bib32","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1056\/NEJMoa1412690","article-title":"Improved overall survival in melanoma with combined dabrafenib and trametinib","volume":"372","author":"Robert","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.wneu.2023.08.137_bib33","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1200\/JCO.2017.73.6785","article-title":"Dabrafenib and trametinib treatment in patients with locally advanced or metastatic BRAF V600-mutant anaplastic thyroid cancer","volume":"36","author":"Subbiah","year":"2018","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.wneu.2023.08.137_bib34","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/s41572-019-0125-9","article-title":"Craniopharyngioma","volume":"5","author":"M\u00fcller","year":"2019","journal-title":"Nat Rev Dis Primers"}],"container-title":["World Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878875023012500?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878875023012500?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T09:30:24Z","timestamp":1761816624000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878875023012500"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":34,"alternative-id":["S1878875023012500"],"URL":"https:\/\/doi.org\/10.1016\/j.wneu.2023.08.137","relation":{},"ISSN":["1878-8750"],"issn-type":[{"value":"1878-8750","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Case Report: Successful Use of BRAF\/MEK Inhibitors in Aggressive BRAF-mutant Craniopharyngioma","name":"articletitle","label":"Article Title"},{"value":"World Neurosurgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.wneu.2023.08.137","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}